|
Dec 4
|
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Dec 1
|
Why Is Glaxo (GSK) Up 5.3% Since Last Earnings Report?
|
|
Nov 30
|
Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue?
|
|
Nov 29
|
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 1.7% Since Last Earnings Report?
|
|
Nov 28
|
Blueprint Medicines to Present at JMP Securities Hematology and Oncology Summit
|
|
Sep 30
|
Director Jeffrey Albers Sells 25,000 Shares of Blueprint Medicines Corp
|